查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439518

尿失禁設備 - 全球市場考量、競爭格局、市場預測 (2030)

Urinary Incontinence Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球尿失禁設備市場規模預計到 2023 年將達到 29.7 億美元，到 2030 年將達到 43 億美元，2024-2030 年預測期間複合年增長率為 6.36%。Masu。 尿失禁病例不斷上升，創新設備不斷發展，人口老化更容易患泌尿系統疾病，如泌尿道感染、骨盆底肌無力、懷孕、糖尿病、更年期、帕金森氏症等疾病，尿失禁設備市場預計將成長。

尿失禁裝置的市場動態

由於尿失禁盛行率不斷上升，尿失禁裝置市場正在顯著成長。 根據美國尿失禁協會 (2018) 的數據，超過 3,300 萬美國人患有某種形式的尿失禁或膀胱疾病。 由於世界各地尿失禁負擔日益增加，尿失禁裝置市場正在顯著成長。

此外，先進的尿失禁設備的開發正在以驚人的速度蓬勃發展。 例如，2020 年 2 月，Atlantic Therapeutics 宣布其治療壓力性尿失禁（SUI）的非侵入性設備獲得美國 FDA 批准，這是一款經過臨床驗證的可穿戴設備，可治療膀胱無力的根本原因。已授予INNOVO® 進行場外交易(OTC) 銷售的許可。 INNOVO® 目前在美國可透過處方購買，並且在全球範圍內已進行了超過 350 萬次安全、成功的治療。 尿失禁裝置領域的此類技術進步可能會推動全球尿失禁裝置市場的發展。

此外，隨著人口老化，泌尿道感染和骨盆底肌無力等泌尿系統疾病也更容易出現尿失禁。 根據阿拉巴馬州泌尿中心 (2018) 的數據，膀胱過動症 (OAB) 可能發生在任何人身上，但最常見於 40 歲以上的男性，尤其是女性。 根據 CentraState Healthcare System (2019) 的數據，三分之一的 40 歲以上女性出現尿失禁症狀，影響全球二分之一的 60 歲以上女性。 對於 80 歲以上的女性來說，沒有某種形式的失禁是比較罕見的。 因此，隨著老年人口的增加，泌尿系統疾病的盛行率預計將增加，從而推動尿失禁市場的成長。

COVID-19 大流行的爆發對世界各地產生了重大影響。 疫情導致門診取消、非急診醫院和程序暫停。 因此，泌尿科會診和相關程序的常規臨床檢查有所減少。 因此，隨著時間的推移，等待透過手術獲得尿失禁裝置的患者數量不斷增加。 因此，預測期內尿失禁裝置的需求加速，成為市場成長的驅動因素。

然而，患者對尿失禁和術後併發症的認識較低等某些因素預計將抑制全球尿失禁設備市場的成長。

尿失禁裝置市場區隔分析

就尿失禁器械市場的產品細分而言，尿道吊帶細分市場預計將在全球尿失禁器械市場中佔據主要份額。 該產品領域的巨大市場份額歸因於越來越多的患者採用這些設備進行快速緩解。 此外，尿道吊帶是先進的設備，已經取代了市面上所有的傳統設備。

此外，這些吊帶由多種材料製成，例如取自患者的韌帶、組織和肌腱，但它們也可以由塑膠等合成材料製成。

女性尿失禁盛行率的增加也增加了對尿道吊帶手術的需求。 此外，尿失禁領域正在進行的重大研究活動預計將提振市場。

此外，我們也看到病患的使用趨勢從傳統設備轉向先進設備。 這增加了患者對尿失禁裝置的可接受性。 因此，所有上述因素預計將推動尿失禁設備市場的成長。

本報告提供了全球尿失禁設備市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章尿失禁設備市場報告簡介

第 2 章尿失禁設備市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第3章監理與專利分析

  • 美國
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第4章尿失禁裝置市場關鍵因素分析

  • 尿失禁設備市場驅動因素
    • 尿失禁盛行率不斷上升
    • 懷孕、糖尿病、更年期和帕金森氏症等疾病
    • 易患泌尿系統疾病的老年人口數量增加
    • 創新設備的開發
  • 尿失禁裝置的抑制因子與挑戰
    • 病人缺乏對失禁的認識
    • 術後併發症
  • 尿失禁裝置的機會
    • 人們對可在家使用的設備越來越感興趣
    • 新興國家的成長機會

第 5 章尿失禁裝置的波特五力分析

第6章COVID-19對尿失禁裝置市場的影響分析

第7章尿失禁裝置市場佈局

  • 按產品
    • 導尿管
    • 尿道吊帶
    • 電刺激裝置
    • 人工尿道括約肌
    • 其他
  • 依類型
    • 體外設備
    • 植入式設備
  • 依患者類型
    • 男性
    • 女性
  • 按最終用戶
    • 醫院、診所
    • 日間手術中心 (ASC)
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章尿失禁設備：全球公司份額分析 - 3 至 5 家主要公司

第9章尿失禁裝置公司及產品簡介

  • NeoTract, Inc.
  • Cook Medical Inc.
  • C.R. Bard Inc.
  • Coloplast Corporation
  • Boston Scientific Corporation
  • Ethicon US, LLC
  • Medtronic PLC
  • A.M.I. Ltd.
  • Teleflex Incorporated
  • Hollister Incorporated
  • ConvaTec Group PLC
  • Caldera Medical Inc.
  • Prosurg, Inc.
  • Laborie, Inc.
  • Becton, Dickinson and Company
  • ZSI Surgical Implants
  • Atlantic Therapeutics
  • B. Braun Melsungen AG
  • Flexicare (Group) Limited
  • InControl Medical

第 10 章專案方法

  • 輔助材料
  • 主要來源
  • 數據三角測量
  • 主要專家意見

第11章KOL瀏覽量

第12章DelveInsight服務內容

第13章免責聲明

第 14 章關於 DelveInsight

Product Code: DIMDCL0339

Urinary Incontinence Devices Market By Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), By Type (External Devices, Internal Devices), By Patient Type (Male, Female), By End-User (Hospitals And Clinics, Ambulatory Surgery Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the development of innovative devices and and surge in urological conditions.

Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030, to reach USD 4.30 billion by 2030. The Urinary Incontinence Devices market is expected to witness growth due to the rising prevalence of urinary incontinence cases, development of innovative devices, aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.

Urinary Incontinence Devices Market Dynamics:

Urinary Incontinence Devices Market has significantly increased due to the rising prevalence of urinary incontinence cases. As per the National Association for Continence 2018, over 33 million Americans suffer from some type of urinary incontinence or bladder condition. Owing to the growing burden of urinary incontinence across the globe, the Urinary Incontinence Devices market has been rising significantly.

In addition, the development of urinary incontinence advanced devices is thriving at a great pace. For instance, in February 2020, Atlantic Therapeutics announced that the US FDA granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive device for non-invasive device for stress urinary incontinence (SUI), clinically proven, and wearable device that treats the root cause of bladder weakness. INNOVO® was previously available in the US by prescription, with more than 3.5 million safe and successful therapy sessions delivered worldwide. Such technological advancement in the field of Urinary Incontinence Devices is likely to boost the Global Urinary Incontinence Devices Market.

Also, the aging population is more prone to urinary incontinence, by the time urological conditions like urinary tract infections and weakening of pelvic floor develop. According to the Urology Centers of Alabama 2018, although overactive bladders (OAB) can happen to anyone, the most common ages are post-40 for men and, especially, women. According to the CentraState Healthcare System, 2019, over the age of 40, one in three women experience symptoms of urinary incontinence, while it affects one in two women over age 60 globally. For women age 80 and older, it's rare not to have some type of incontinence. Therefore, as the aging population increases, there will be more prevalence of urological conditions, which will eventually boost the growth of the Urinary Incontinence market.

The outbreak of the COVID-19 pandemic had a profound impact across the globe. The pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the urological visits and related procedures. Thus, the number of patients waiting to get urinary incontinence devices through surgery increased over time. Therefore, the demand for Urinary Incontinence Devices has accelerated over the forecast period which will drive the market growth.

However, certain factors like less awareness among the patient population regarding incontinence and post-operative complications are expected to restrict the growth of the Global Urinary Incontinence Devices Market.

Urinary Incontinence Devices Market Segment Analysis:

Urinary Incontinence Devices Market by Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), by Type (External Devices, Internal Devices), by Patient Type (Male, Female), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers, Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Urinary Incontinence Devices market product segment, the Urethral Slings market segment will hold the major share of the Global Urinary Incontinence Devices market. The large market share of this product segment can be attributed to the growing patient adoption for these devices due to quick relief. Moreover, Urethral Slings are more advanced devices and have replaced all the conventional devices available in the market.

Furthermore, these slings are made up of different materials like ligament, tissue, tendons taken from the patient or they can also be manufactured from synthetic sources like plastic.

The rising prevalence of urinary incontinence among the women population is also increasing the demand for urethral sling surgery. Moreover, the significant research activities taking place in the Urinary Incontinence arena will eventually boost the market.

Additionally, a shift in trend from conventional devices to advanced devices can be seen among the patient population. This will increase the acceptance of Urinary Incontinence Devices for patients. Hence, all the above-mentioned factors are expected to drive the segment growth of the Urinary Incontinence Devices market.

North America Is Expected To Dominate The Overall Global Urinary Incontinence Devices Market:

North America is expected to dominate the overall Urinary Incontinence Devices market during the forecast period. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region. As per Urology Care Foundation 2022, a quarter to a third of men and women in the US suffer from urinary incontinence. About 33 million have overactive bladder representing symptoms of urgency, frequency, and urge incontinence.

According to the same statistics, as many as 30% of men and 40% of women in the United States live with OAB symptoms. Thus, the burgeoning cases of the diseases will contribute to the growth of the Urinary Incontinence Devices Market in the region as the demand will increase.

Further, in North America and at the global level the United States represents the largest market worldwide supported by the development of advanced devices and easy regulatory initiatives by the government. One such technological advancement is the development of implantable tibial neuromodulation (TNM) device designed to provide relief from symptoms of bladder incontinence, developed by Medtronic PLC. The device received approval from US FDA to proceed with an investigational device exemption (IDE) trial in April 2022.

Europe and Asia-Pacific region have the future potential growth for the Global Urinary Incontinence Devices market. This is owing to the rising burden of urological diseases and COVID-19 pandemic in the European region countries and Asian countries. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Urinary Incontinence Devices market. For instance, in April 2022, in Australia, Analytica Ltd. signed a joint venture agreement with Hebei Nacol Bio-Technology Co. Ltd. and Shijiazhuang Biosphere Pty Ltd., of Hebei Province, China, to manufacture and distribute its Pericoach device for urinary incontinence in China, Macau, Hong Kong, and Taiwan. Such initiatives are anticipated to boost the Urinary Incontinence Devices Market.

Urinary Incontinence Devices Market Key Players:

Some of the key market players operating in the Global Urinary Incontinence Devices Market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical among others.

Recent Developmental Activities in the Urinary Incontinence Devices Market:

In September 2022, at American Urological Association Annual Meeting, a novel, ultra-miniaturized sacral nerve modulation (SNM) system was shown to be both efficacious and safe in treating patients with urge urinary incontinence (UUI), according to findings from the feasibility phase of the SANS-UUI study.

In May 2022, the University of Washington School of Medicine developed and tested 3 new devices to relieve symptoms of urinary incontinence. The first device tested in a clinical trial was a neuromodulation device. The second device involves an electrode about the size of a small pill and is implanted through a needle in the lower back alongside one of the main pelvic nerves. The third device is a soft, rubber ring with embedded electrodes placed in the vagina like a pessary or diaphragm.

Key Takeaways from the Urinary Incontinence Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urinary Incontinence Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Urinary Incontinence Devices Market.

Various opportunities are available for the other competitor in the Urinary Incontinence Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Urinary Incontinence Devices market growth in the coming future?

Target Audience who can be benefited from this Urinary Incontinence Devices Market Report Study

Urinary Incontinence Devices providers

Research organizations and consulting companies

Urinary Incontinence Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Urinary Incontinence Devices

Various End-users want to know more about the Urinary Incontinence Devices Market and the latest technological developments in the Urinary Incontinence Devices market.

Frequently Asked Questions for Urinary Incontinence Devices Market:

1. What are Urinary Incontinence Devices?

Urinary Incontinence Devices are medical devices that help in collecting and holding urine. Urinary Incontinence (UI) is a medical disorder in which a person unconsciously urinates. It is differentiated into four types namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence.

2. What is the market for Global Urinary Incontinence Devices?

Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030, to reach USD 4.30 billion by 2030.

3. What are the drivers for Global Urinary Incontinence Devices?

The major drivers driving the demand for Urinary Incontinence Devices are the rising prevalence of urinary incontinence cases, the development of innovative devices, the aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.

4. Who are the key players operating in Global Urinary Incontinence Devices?

Some of the key market players operating in the Urinary Incontinence Devices market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical, and others.

5. Which region has the highest share in the Urinary Incontinence Devices market?

North America is expected to dominate the overall global Urinary Incontinence Devices market during the forecast period from 2024 to 2030. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region.

Table of Contents

1. Urinary Incontinence Devices Market Report Introduction

2. Urinary Incontinence Devices Market Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. The U.K.
  • 3.3. Japan

4. Urinary Incontinence Devices Market Key factors analysis

  • 4.1. Urinary Incontinence Devices Market Drivers
    • 4.1.1. Rising prevalence of urinary incontinence cases
    • 4.1.2. The conditions including pregnancy, diabetes, menopause, and Parkinson's diseases
    • 4.1.3. The surge in the aging population prone to urological conditions
    • 4.1.4. Development of innovative devices
  • 4.2. Urinary Incontinence Devices Restraints and Challenges
    • 4.2.1. Less awareness among the patient population regarding incontinence
    • 4.2.2. Post-operative complications
  • 4.3. Urinary Incontinence Devices Opportunities
    • 4.3.1. Growing preference for devices that can be used in home settings
    • 4.3.2. Growth opportunities in emerging countries

5. Urinary Incontinence Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Urinary Incontinence Devices Market

7. Urinary Incontinence Devices Market layout

  • 7.1. By Product
    • 7.1.1. Urinary Catheters
    • 7.1.2. Urethral Slings
    • 7.1.3. Electrical Stimulation Devices
    • 7.1.4. Artificial Urinary Sphincters
    • 7.1.5. Others
  • 7.2. By Type
    • 7.2.1. External Devices
    • 7.2.2. Internal Devices
  • 7.3. By Patient Type
    • 7.3.1. Male
    • 7.3.2. Female
  • 7.4. By End User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgical Centers (ASCs)
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Urinary Incontinence Devices Market, by Product
      • 7.5.1.2. North America Urinary Incontinence Devices Market, by Type
      • 7.5.1.3. North America Urinary Incontinence Devices Market, by Patient Type
      • 7.5.1.4. North America Urinary Incontinence Devices Market, by End User
      • 7.5.1.5. North America Urinary Incontinence Devices Market, by Country
      • 7.5.1.5.1. United States
      • 7.5.1.5.2. Canada
      • 7.5.1.5.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Urinary Incontinence Devices Market, by Product
      • 7.5.2.2. Europe Urinary Incontinence Devices Market, by Type
      • 7.5.2.3. Europe Urinary Incontinence Devices Market, by Patient Type
      • 7.5.2.4. Europe Urinary Incontinence Devices Market, by End User
      • 7.5.2.5. Europe Urinary Incontinence Devices Market, by Country
      • 7.5.2.5.1. France
      • 7.5.2.5.2. Germany
      • 7.5.2.5.3. United Kingdom
      • 7.5.2.5.4. Italy
      • 7.5.2.5.5. Spain
      • 7.5.2.5.6. Russia
      • 7.5.2.5.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Urinary Incontinence Devices Market, by Product
      • 7.5.3.2. Asia-Pacific Urinary Incontinence Devices Market, by Type
      • 7.5.3.3. Asia-Pacific Urinary Incontinence Devices Market, by Patient Type
      • 7.5.3.4. Asia-Pacific Urinary Incontinence Devices Market, by End User
      • 7.5.3.5. Asia-Pacific Urinary Incontinence Devices Market, by Country
      • 7.5.3.5.1. China
      • 7.5.3.5.2. Japan
      • 7.5.3.5.3. India
      • 7.5.3.5.4. Australia
      • 7.5.3.5.5. South Korea
      • 7.5.3.5.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Urinary Incontinence Devices Market, by Product
      • 7.5.4.2. RoW Urinary Incontinence Devices Market, by Type
      • 7.5.4.3. RoW Urinary Incontinence Devices Market, by Patient Type
      • 7.5.4.4. RoW Urinary Incontinence Devices Market, by End User
      • 7.5.4.5. RoW Urinary Incontinence Devices Market, by Region
      • 7.5.4.5.1. Middle East
      • 7.5.4.5.2. Africa
      • 7.5.4.5.3. South America

8. Urinary Incontinence Devices Global Company Share Analysis - Key 3-5 Companies

9. Urinary Incontinence Devices Company and Product Profiles

  • 9.1. NeoTract, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Cook Medical Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. C.R. Bard Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Coloplast Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Boston Scientific Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Ethicon US, LLC
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Medtronic PLC
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. A.M.I. Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Teleflex Incorporated
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Hollister Incorporated
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. ConvaTec Group PLC
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Caldera Medical Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Prosurg, Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Laborie, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Becton, Dickinson and Company
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. ZSI Surgical Implants
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Atlantic Therapeutics
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. B. Braun Melsungen AG
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Flexicare (Group) Limited
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. InControl Medical
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Urinary Incontinence Devices Market
  • Table 3: Urinary Incontinence Devices Market Analysis in Global (2021-2030)
  • Table 4: Urinary Incontinence Devices Market Analysis in Global by Product (2021-2030)
  • Table 5: Urinary Incontinence Devices Market Analysis in Global by Type (2021-2030)
  • Table 6: Urinary Incontinence Devices Market Analysis in Global by Patient Type (2021-2030)
  • Table 7: Urinary Incontinence Devices Market Analysis in Global by End User (2021-2030)
  • Table 8: Urinary Incontinence Devices Market Analysis in Global by Geography (2021-2030)
  • Table 9: Urinary Incontinence Devices Market Analysis in North America (2021-2030)
  • Table 10: Urinary Incontinence Devices Market Analysis in North America by Product (2021-2030)
  • Table 11: Urinary Incontinence Devices Market Analysis in North America by Type (2021-2030)
  • Table 12: Urinary Incontinence Devices Market Analysis in North America by Patient Type (2021-2030)
  • Table 13: Urinary Incontinence Devices Market Analysis in North America by End User (2021-2030)
  • Table 14: Urinary Incontinence Devices Market Analysis in North America by Country (2021-2030)
  • Table 15: Urinary Incontinence Devices Market Analysis in the US (2021-2030)
  • Table 16: Urinary Incontinence Devices Market Analysis in Canada (2021-2030)
  • Table 17: Urinary Incontinence Devices Market Analysis in Mexico (2021-2030)
  • Table 18: Urinary Incontinence Devices Market Analysis in Europe (2021-2030)
  • Table 19: Urinary Incontinence Devices Market Analysis in Europe by Product (2021-2030)
  • Table 20: Urinary Incontinence Devices Market Analysis in Europe by Type (2021-2030)
  • Table 21: Urinary Incontinence Devices Market Analysis in Europe by Patient Type (2021-2030)
  • Table 22: Urinary Incontinence Devices Market Analysis in Europe by End User (2021-2030)
  • Table 23: Urinary Incontinence Devices Market Analysis in Europe by Country (2021-2030)
  • Table 24: Urinary Incontinence Devices Market Analysis in France (2021-2030)
  • Table 25: Urinary Incontinence Devices Market Analysis in Germany (2021-2030)
  • Table 26: Urinary Incontinence Devices Market Analysis in UK (2021-2030)
  • Table 27: Urinary Incontinence Devices Market Analysis in Italy (2021-2030)
  • Table 28: Urinary Incontinence Devices Market Analysis in Spain (2021-2030)
  • Table 29: Urinary Incontinence Devices Market Analysis in Russia (2021-2030)
  • Table 30: Urinary Incontinence Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 31: Urinary Incontinence Devices Market Analysis in Asia Pacific (2021-2030)
  • Table 32: Urinary Incontinence Devices Market Analysis in Asia Pacific by Product (2021-2030)
  • Table 33: Urinary Incontinence Devices Market Analysis in Asia Pacific by Type (2021-2030)
  • Table 34: Urinary Incontinence Devices Market Analysis in Asia Pacific by Patient Type (2021-2030)
  • Table 35: Urinary Incontinence Devices Market Analysis in Asia Pacific by End User (2021-2030)
  • Table 36: Urinary Incontinence Devices Market Analysis in Asia Pacific by Country (2021-2030)
  • Table 37: Urinary Incontinence Devices Market Analysis in China (2021-2030)
  • Table 38: Urinary Incontinence Devices Market Analysis in Japan (2021-2030)
  • Table 39: Urinary Incontinence Devices Market Analysis in India (2021-2030)
  • Table 40: Urinary Incontinence Devices Market Analysis in Australia (2021-2030)
  • Table 41: Urinary Incontinence Devices Market Analysis in South Korea (2021-2030)
  • Table 42: Urinary Incontinence Devices Market Analysis in Rest of Asia Pacific (2021-2030)
  • Table 43: Urinary Incontinence Devices Market Analysis in Rest of the World (2021-2030)
  • Table 44: Urinary Incontinence Devices Market Analysis in Rest of the World by Product (2021-2030)
  • Table 45: Urinary Incontinence Devices Market Analysis in Rest of the World by Type (2021-2030)
  • Table 46: Urinary Incontinence Devices Market Analysis in Rest of the World by Patient Type (2021-2030)
  • Table 47: Urinary Incontinence Devices Market Analysis in Rest of the World by End User (2021-2030)
  • Table 48: Urinary Incontinence Devices Market Analysis in Rest of the World by Country (2021-2030)
  • Table 49: Urinary Incontinence Devices Market Analysis in Middle East (2021-2030)
  • Table 50: Urinary Incontinence Devices Market Analysis in Africa (2021-2030)
  • Table 51: Urinary Incontinence Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Urinary Incontinence Devices Market
  • Figure 3: Urinary Incontinence Devices Market Analysis in Global (2021-2030)
  • Figure 4: Urinary Incontinence Devices Market Analysis in Global by Product (2021-2030)
  • Figure 5: Urinary Incontinence Devices Market Analysis in Global by Type (2021-2030)
  • Figure 6: Urinary Incontinence Devices Market Analysis in Global by Patient Type (2021-2030)
  • Figure 7: Urinary Incontinence Devices Market Analysis in Global by End User (2021-2030)
  • Figure 8: Urinary Incontinence Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 9: Urinary Incontinence Devices Market Analysis in North America (2021-2030)
  • Figure 10: Urinary Incontinence Devices Market Analysis in North America by Product (2021-2030)
  • Figure 11: Urinary Incontinence Devices Market Analysis in North America by Type (2021-2030)
  • Figure 12: Urinary Incontinence Devices Market Analysis in North America by Patient Type (2021-2030)
  • Figure 13: Urinary Incontinence Devices Market Analysis in North America by End User (2021-2030)
  • Figure 14: Urinary Incontinence Devices Market Analysis in North America by Country (2021-2030)
  • Figure 15: Urinary Incontinence Devices Market Analysis in the US (2021-2030)
  • Figure 16: Urinary Incontinence Devices Market Analysis in Canada (2021-2030)
  • Figure 17: Urinary Incontinence Devices Market Analysis in Mexico (2021-2030)
  • Figure 18: Urinary Incontinence Devices Market Analysis in Europe (2021-2030)
  • Figure 19: Urinary Incontinence Devices Market Analysis in Europe by Product (2021-2030)
  • Figure 20: Urinary Incontinence Devices Market Analysis in Europe by Type (2021-2030)
  • Figure 21: Urinary Incontinence Devices Market Analysis in Europe by Patient Type (2021-2030)
  • Figure 22: Urinary Incontinence Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 23: Urinary Incontinence Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 24: Urinary Incontinence Devices Market Analysis in France (2021-2030)
  • Figure 25: Urinary Incontinence Devices Market Analysis in Germany (2021-2030)
  • Figure 26: Urinary Incontinence Devices Market Analysis in UK (2021-2030)
  • Figure 27: Urinary Incontinence Devices Market Analysis in Italy (2021-2030)
  • Figure 28: Urinary Incontinence Devices Market Analysis in Spain (2021-2030)
  • Figure 29: Urinary Incontinence Devices Market Analysis in Russia (2021-2030)
  • Figure 30: Urinary Incontinence Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 31: Urinary Incontinence Devices Market Analysis in Asia Pacific (2021-2030)
  • Figure 32: Urinary Incontinence Devices Market Analysis in Asia Pacific by Product (2021-2030)
  • Figure 33: Urinary Incontinence Devices Market Analysis in Asia Pacific by Type (2021-2030)
  • Figure 34: Urinary Incontinence Devices Market Analysis in Asia Pacific by Patient Type (2021-2030)
  • Figure 35: Urinary Incontinence Devices Market Analysis in Asia Pacific by End User (2021-2030)
  • Figure 36: Urinary Incontinence Devices Market Analysis in Asia Pacific by Country (2021-2030)
  • Figure 37: Urinary Incontinence Devices Market Analysis in China (2021-2030)
  • Figure 38: Urinary Incontinence Devices Market Analysis in Japan (2021-2030)
  • Figure 39: Urinary Incontinence Devices Market Analysis in India (2021-2030)
  • Figure 40: Urinary Incontinence Devices Market Analysis in Australia (2021-2030)
  • Figure 41: Urinary Incontinence Devices Market Analysis in South Korea (2021-2030)
  • Figure 42: Urinary Incontinence Devices Market Analysis in Rest of Asia Pacific (2021-2030)
  • Figure 43: Urinary Incontinence Devices Market Analysis in Rest of the World (2021-2030)
  • Figure 44: Urinary Incontinence Devices Market Analysis in Rest of the World by Product (2021-2030)
  • Figure 45: Urinary Incontinence Devices Market Analysis in Rest of the World by Type (2021-2030)
  • Figure 46: Urinary Incontinence Devices Market Analysis in Rest of the World by Patient Type (2021-2030)
  • Figure 47: Urinary Incontinence Devices Market Analysis in Rest of the World by End User (2021-2030)
  • Figure 48: Urinary Incontinence Devices Market Analysis in Rest of the World by Country (2021-2030)
  • Figure 49: Urinary Incontinence Devices Market Analysis in Middle East (2021-2030)
  • Figure 50: Urinary Incontinence Devices Market Analysis in Africa (2021-2030)
  • Figure 51: Urinary Incontinence Devices Market Analysis in South America (2021-2030)
  • Figure 52: Market Drivers
  • Figure 53: Market Barriers
  • Figure 54: Market Opportunities
  • Figure 55: PORTER'S Five Force Analysis